Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aldo-keto reductase family 1 member B1 pseudogene 4 (AKR1B1P4) is a nonfunctional DNA segment derived from the AKR1B1 gene, which encodes aldose reductase, an enzyme of the aldo-keto reductase (AKR) superfamily. As a pseudogene, AKR1B1P4 does not produce a functional protein and is generally considered non-essential and inactive biologically. It may serve as a genomic relic rather than a therapeutic target or relevant biomarker in disease[1][2][6]. Pseudogenes typically have no direct biological or disease role, although some rare pseudogenes may influence gene regulation or be implicated in disease via non-protein-coding mechanisms, but no such roles are described for AKR1B1P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldo-keto reductase family 1 member B1 pseudogene 4 (AKR1B1P4).